Pycnogenol has more published skin trials than almost any other botanical supplement. The evidence for elasticity, hydration, and hyperpigmentation is real — and the mechanism is unusually well characterised.
Pycnogenol is a standardised extract of French maritime pine bark (Pinus pinaster), containing a mixture of procyanidins, bioflavonoids, and phenolic acids. It has been the subject of over 160 published studies and more than 40 clinical trials — an unusually large evidence base for a botanical supplement. The skin evidence specifically spans elasticity, hydration, hyperpigmentation, and photoprotection, with multiple randomised controlled trials.
Pycnogenol's skin effects appear to operate through four distinct mechanisms. First, it acts as a potent antioxidant — its procyanidins neutralise free radicals in both aqueous and lipid phases. Second, it inhibits MMP activity, protecting collagen and elastin from enzymatic degradation. Third, it stimulates collagen and hyaluronic acid synthesis in fibroblasts — the Marini et al. (2012) trial found a 44% increase in hyaluronic acid synthase levels in skin biopsies. Fourth, it inhibits tyrosinase activity and downregulates melanogenesis-related mediators, reducing hyperpigmentation.
The Marini et al. (2012) trial (n=20, women aged 55–68, 75 mg/day for 12 weeks) found a 25% improvement in skin elasticity and a 21% increase in skin hydration compared to placebo. These are substantial effect sizes for an oral supplement. The mechanistic data from skin biopsies — showing increased hyaluronic acid synthase expression — provides a plausible explanation for the hydration improvement.
A 2021 trial by Zhao et al. (n=76, urban outdoor workers, 100 mg/day for 12 weeks) found a 13.8% improvement in skin tone regularity, a 13% improvement in skin elasticity, and a 14% decrease in TEWL. This trial is particularly relevant because it was conducted in a population with high UV exposure — testing Pycnogenol's photoprotective properties in real-world conditions.
Two trials have examined Pycnogenol specifically for melasma — a common form of hyperpigmentation. Ni et al. (2002, n=30, 75 mg/day for 4 weeks) found a 22% reduction in pigment intensity and a 38% decrease in over-pigmented skin spots. Pinto et al. (2015, n=31, 75 mg/day for 90 days) found a 58% reduction in the Melasma Area and Severity Index (MASI) and a 29% improvement in melasma quality-of-life scores.
58% reduction in MASI score. 25% improvement in skin elasticity. 44% increase in hyaluronic acid synthase. These are the most consistent effect sizes in the Pycnogenol skin literature.
— Pinto et al. 2015; Marini et al. 2012
The melasma evidence is particularly notable because melasma is notoriously difficult to treat. Standard treatments (hydroquinone, azelaic acid, kojic acid) have significant side effect profiles. Pycnogenol's efficacy in this area, if replicated in larger trials, would represent a clinically meaningful alternative.
The effective dose across trials is 75–100 mg/day. Pycnogenol has an excellent safety profile — over 50 years of human use and no serious adverse events reported in clinical trials at these doses. It is not recommended during pregnancy (insufficient safety data) and may interact with immunosuppressants.
Vitaei verdict
Pycnogenol has Tier II evidence for skin elasticity, hydration, and hyperpigmentation at 75–100 mg/day. The evidence base is unusually large for a botanical supplement, and the mechanistic data (hyaluronic acid synthase upregulation, MMP inhibition, tyrosinase inhibition) is coherent with the clinical outcomes. It is one of the better-evidenced oral supplements for skin ageing.
Skin ageing at the cellular level: the 12 hallmarks applied to skin
The same nine — now twelve — hallmarks that drive systemic ageing play out in skin with unusual visibility. Understanding them explains why some interventions work and most don't.
Astaxanthin vs vitamin C for skin: a head-to-head evidence review
Both are antioxidants. Both have RCT evidence for skin outcomes. But they work through different mechanisms, target different problems, and the evidence for each is stronger in different areas.
The UV damage cascade: how sun exposure ages skin at the molecular level
Photoaging accounts for 80% of extrinsic skin ageing. Understanding the molecular cascade — from photon to wrinkle — explains why sunscreen is the most evidence-supported anti-ageing intervention available.